Chemfab Alkalis [CHEMFAB] vs Grauer & Weil [GRAUWEIL] Detailed Stock Comparison

Chemfab Alkalis
NSE
Loading...

Grauer & Weil
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Chemfab Alkalis wins in 7 metrics, Grauer & Weil wins in 13 metrics, with 0 ties. Grauer & Weil appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Chemfab Alkalis | Grauer & Weil | Better |
---|---|---|---|
P/E Ratio (TTM) | 160.23 | 26.73 | Grauer & Weil |
Price-to-Book Ratio | 2.58 | 4.48 | Chemfab Alkalis |
Debt-to-Equity Ratio | 22.20 | 1.26 | Grauer & Weil |
PEG Ratio | 0.89 | 37.25 | Chemfab Alkalis |
EV/EBITDA | 20.42 | 20.89 | Chemfab Alkalis |
Profit Margin (TTM) | -1.51% | 13.35% | Grauer & Weil |
Operating Margin (TTM) | 5.36% | 18.36% | Grauer & Weil |
EBITDA Margin (TTM) | 5.36% | 18.36% | Grauer & Weil |
Return on Equity | -1.83% | 16.73% | Grauer & Weil |
Return on Assets (TTM) | -1.33% | 12.23% | Grauer & Weil |
Free Cash Flow (TTM) | $399.09M | $999.80M | Grauer & Weil |
Dividend Yield | 0.17% | 1.05% | Grauer & Weil |
1-Year Return | -23.19% | -0.82% | Grauer & Weil |
Price-to-Sales Ratio (TTM) | 2.81 | 3.74 | Chemfab Alkalis |
Enterprise Value | $10.47B | $36.79B | Grauer & Weil |
EV/Revenue Ratio | 3.00 | 3.27 | Chemfab Alkalis |
Gross Profit Margin (TTM) | 34.21% | 41.05% | Grauer & Weil |
Revenue per Share (TTM) | $244 | $25 | Chemfab Alkalis |
Earnings per Share (Diluted) | $-3.69 | $3.47 | Grauer & Weil |
Beta (Stock Volatility) | -0.61 | 0.28 | Chemfab Alkalis |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Chemfab Alkalis vs Grauer & Weil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Chemfab Alkalis | -0.24% | 0.60% | -8.23% | -18.98% | -23.88% | -33.77% |
Grauer & Weil | 0.05% | -2.32% | -11.54% | 9.08% | 6.92% | -11.88% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Chemfab Alkalis | -23.19% | 180.02% | 318.75% | 202.39% | 202.39% | 202.39% |
Grauer & Weil | -0.82% | 39.06% | 116.96% | 385.60% | 953.98% | 726.65% |
Performance & Financial Health Analysis: Chemfab Alkalis vs Grauer & Weil
Metric | CHEMFAB | GRAUWEIL |
---|---|---|
Market Information | ||
Market Cap | ₹9.83B | ₹42.05B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 16,882 | 141,218 |
90 Day Avg. Volume | 11,005 | 163,561 |
Last Close | ₹683.40 | ₹92.75 |
52 Week Range | ₹650.05 - ₹1,230.00 | ₹78.00 - ₹120.00 |
% from 52W High | -44.44% | -22.71% |
All-Time High | ₹1,230.00 (Oct 14, 2024) | ₹204.80 (Feb 26, 2024) |
% from All-Time High | -44.44% | -54.71% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.20% | -0.04% |
Quarterly Earnings Growth | 1.84% | -0.14% |
Financial Health | ||
Profit Margin (TTM) | -0.02% | 0.13% |
Operating Margin (TTM) | 0.05% | 0.18% |
Return on Equity (TTM) | -0.02% | 0.17% |
Debt to Equity (MRQ) | 22.20 | 1.26 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹264.55 | ₹20.72 |
Cash per Share (MRQ) | ₹14.72 | ₹11.87 |
Operating Cash Flow (TTM) | ₹-3,054,000 | ₹1.68B |
Levered Free Cash Flow (TTM) | ₹-69,403,000 | ₹1.57B |
Dividends | ||
Last 12-Month Dividend Yield | 0.17% | 1.05% |
Last 12-Month Dividend | ₹1.25 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Chemfab Alkalis vs Grauer & Weil
Metric | CHEMFAB | GRAUWEIL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 160.23 | 26.73 |
Forward P/E | N/A | 37.25 |
PEG Ratio | 0.89 | 37.25 |
Price to Sales (TTM) | 2.81 | 3.74 |
Price to Book (MRQ) | 2.58 | 4.48 |
Market Capitalization | ||
Market Capitalization | ₹9.83B | ₹42.05B |
Enterprise Value | ₹10.47B | ₹36.79B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 3.00 | 3.27 |
Enterprise to EBITDA | 20.42 | 20.89 |
Risk & Other Metrics | ||
Beta | -0.61 | 0.28 |
Book Value per Share (MRQ) | ₹264.55 | ₹20.72 |
Financial Statements Comparison: Chemfab Alkalis vs Grauer & Weil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | CHEMFAB | GRAUWEIL |
---|---|---|
Revenue/Sales | ₹915.41M | ₹3.40B |
Cost of Goods Sold | ₹602.29M | ₹2.00B |
Gross Profit | ₹313.12M | ₹1.40B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹49.07M | ₹237.20M |
EBITDA | ₹126.59M | ₹417.40M |
Pre-Tax Income | ₹47.00M | ₹343.50M |
Income Tax | ₹21.52M | ₹86.10M |
Net Income (Profit) | ₹25.48M | ₹257.40M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | CHEMFAB | GRAUWEIL |
---|---|---|
Cash & Equivalents | ₹47.01M | ₹1.08B |
Total Current Assets | ₹1.19B | ₹9.36B |
Total Current Liabilities | ₹721.99M | ₹2.97B |
Long-Term Debt | ₹652.06M | ₹37.30M |
Total Shareholders Equity | ₹3.80B | ₹9.39B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹3.17B | ₹2.47B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | CHEMFAB | GRAUWEIL |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | CHEMFAB | GRAUWEIL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 16,882 | 141,218 |
Average Daily Volume (90 Day) | 11,005 | 163,561 |
Shares Outstanding | 14.36M | 453.41M |
Float Shares | 3.18M | 127.47M |
% Held by Insiders | 0.76% | 0.72% |
% Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Chemfab Alkalis vs Grauer & Weil
Metric | CHEMFAB | GRAUWEIL |
---|---|---|
Last 12-Month Dividend | ₹1.25 | ₹1.00 |
Last 12-Month Dividend Yield | 0.17% | 1.05% |
3-Year Avg Annual Dividend | ₹1.25 | ₹0.58 |
3-Year Avg Dividend Yield | 0.27% | 0.45% |
3-Year Total Dividends | ₹3.75 | ₹1.73 |
Ex-Dividend Date | Sep 13, 2024 | Aug 06, 2025 |